Fosfomycin, from susceptibility to resistance: Impact of the new guidelines on breakpoints

E Farfour, N Degand, E Riverain, V Fihman… - Médecine et Maladies …, 2020 - Elsevier
The fosfomycin breakpoint using the disc diffusion method (DDM) changed in the 2019 CA-
SFM/EUCAST guidelines v2 (24 mm versus 19 mm). We assessed its impact on …

[HTML][HTML] Performance of disk diffusion and broth microdilution for fosfomycin susceptibility testing of multidrug-resistant clinical isolates of Enterobacterales and …

MF Mojica, E De La Cadena… - Journal of Global …, 2020 - Elsevier
Objectives This study aimed to evaluate the susceptibility of clinical isolates of
Enterobacterales and Pseudomonas aeruginosa to fosfomycin and to determine the …

Assessment of the susceptibility of clinical Gram-negative and Gram-positive bacterial strains to fosfomycin and significance of this antibiotic in infection treatment

B Kowalska-Krochmal, B Mączyńska… - Pathogens, 2022 - mdpi.com
Multidrug resistance of bacteria has prompted intensive development work on new
medicines, but also the search for effective options among the oldest antibiotics. Although …

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review

ME Falagas, AC Kastoris, AM Kapaskelis… - The Lancet infectious …, 2010 - thelancet.com
Rising rates of resistance to antimicrobial drugs among Enterobacteriaceae limit the choice
of reliably active forms of these drugs. We evaluated the evidence on fosfomycin as a …

Fosfomycin: a review

NK Shrestha, JW Tomford - Infectious Diseases in Clinical Practice, 2001 - journals.lww.com
Downloaded from by BhDMf5ePHKbH4TTImqenVA+
lpWIIBvonhQl60Etgtdnn9T1vLQWJq3kbRMjK/ocE on 11/17/2023 toca, Klebsiella …

Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: the Importance of Heteroresistance for …

IJ Abbott, E Van Gorp, RA Wijma… - Antimicrobial Agents …, 2020 - Am Soc Microbiol
Oral fosfomycin trometamol is licensed as a single oral dose for the treatment of
uncomplicated urinary tract infections, with activity against multidrug-resistant uropathogens …

Performance Evaluation of BD Phoenix and MicroScan WalkAway Plus for Determination of Fosfomycin Susceptibility in Enterobacterales

A Bondi, A Curtoni, M Peradotto, E Zanotto, M Boattini… - Antibiotics, 2023 - mdpi.com
Background: Fosfomycin is an old bactericidal drug that has gained increasing interest in the
last decade for its potential use in multi-drug resistant gram-negative infections. However …

Clinical appraisal of fosfomycin in the era of antimicrobial resistance

S Sastry, LG Clarke, H Alrowais… - Antimicrobial Agents …, 2015 - Am Soc Microbiol
Fosfomycin is recommended as one of the first-line agents for treatment of urinary tract
infections (UTIs) in the latest guidelines endorsed by the Infectious Diseases Society of …

[HTML][HTML] Evaluation of the commercial AD fosfomycin test for susceptibility testing of multidrug-resistant Enterobacterales and Pseudomonas aeruginosa

EM Parisio, G Camarlinghi, M Coppi, C Niccolai… - Clinical Microbiology …, 2021 - Elsevier
Objectives To compare fosfomycin susceptibility testing with the commercial agar dilution
(AD) test, AD Fosfomycin (Liofilchem, Roseto degli Abruzzi, Italy) and the reference AD …

Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature

KZ Vardakas, NJ Legakis, N Triarides… - International journal of …, 2016 - Elsevier
The aim of this review was to evaluate the susceptibility of contemporary Gram-positive and
Gram-negative bacteria to fosfomycin. PubMed and Scopus databases were systematically …